These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33242360)

  • 21. The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota.
    LaCourse KD; Zepeda-Rivera M; Kempchinsky AG; Baryiames A; Minot SS; Johnston CD; Bullman S
    Cell Rep; 2022 Nov; 41(7):111625. PubMed ID: 36384132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two primer-probe sets of
    Yamaoka Y; Sasai M; Suehiro Y; Hashimoto S; Goto A; Yamamoto N; Suzuki N; Higaki S; Fujii I; Suzuki C; Matsumoto T; Hoshida T; Koga M; Tsutsumi T; Lim LA; Matsubara Y; Tomochika S; Yoshida S; Hazama S; Yotsuyanagi H; Nagano H; Sakaida I; Takami T; Yamasaki T
    Ann Clin Biochem; 2022 Nov; 59(6):396-403. PubMed ID: 35821582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
    Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway.
    Yu J; Chen Y; Fu X; Zhou X; Peng Y; Shi L; Chen T; Wu Y
    Int J Cancer; 2016 Sep; 139(6):1318-26. PubMed ID: 27130618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.
    Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S
    J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade.
    Chen Y; Peng Y; Yu J; Chen T; Wu Y; Shi L; Li Q; Wu J; Fu X
    Oncotarget; 2017 May; 8(19):31802-31814. PubMed ID: 28423670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers.
    Chen Y; Lu Y; Ke Y; Li Y
    Medicine (Baltimore); 2019 Sep; 98(39):e17221. PubMed ID: 31574832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
    Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
    J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Hussan H; Clinton SK; Roberts K; Bailey MT
    World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study.
    Eisele Y; Mallea PM; Gigic B; Stephens WZ; Warby CA; Buhrke K; Lin T; Boehm J; Schrotz-King P; Hardikar S; Huang LC; Pickron TB; Scaife CL; Viskochil R; Koelsch T; Peoples AR; Pletneva MA; Bronner M; Schneider M; Ulrich AB; Swanson EA; Toriola AT; Shibata D; Li CI; Siegel EM; Figueiredo J; Janssen KP; Hauner H; Round J; Ulrich CM; Holowatyj AN; Ose J
    Clin Colorectal Cancer; 2021 Sep; 20(3):e165-e172. PubMed ID: 33935016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study.
    Shariati A; Razavi S; Ghaznavi-Rad E; Jahanbin B; Akbari A; Norzaee S; Darban-Sarokhalil D
    Infect Agent Cancer; 2021 Jun; 16(1):41. PubMed ID: 34108031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replication Study:
    Repass J;
    Elife; 2018 Mar; 7():. PubMed ID: 29533182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RETRACTED: Comparison between diagnostic performance of intestinal Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli in 5-fluorouracil resistance to colorectal cancer: A meta‑analysis.
    Wang WY; Zhou H; Wang Z; Zhang YH
    Cancer Treat Res Commun; 2022; 32():100536. PubMed ID: 35567912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer.
    Wang N; Fang JY
    Trends Microbiol; 2023 Feb; 31(2):159-172. PubMed ID: 36058786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial Community Heterogeneity Within Colorectal Neoplasia and its Correlation With Colorectal Carcinogenesis.
    Liu W; Zhang X; Xu H; Li S; Lau HC; Chen Q; Zhang B; Zhao L; Chen H; Sung JJ; Yu J
    Gastroenterology; 2021 Jun; 160(7):2395-2408. PubMed ID: 33581124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer.
    Suraweera N; Mouradov D; Li S; Jorissen RN; Hampson D; Ghosh A; Sengupta N; Thaha M; Ahmed S; Kirwan M; Aleva F; Propper D; Feakins RM; Vulliamy T; Elwood NJ; Tian P; Ward RL; Hawkins NJ; Xu ZZ; Molloy PL; Jones IT; Croxford M; Gibbs P; Silver A; Sieber OM
    Oncotarget; 2016 Jun; 7(24):36474-36488. PubMed ID: 27167335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of
    Yan X; Liu L; Li H; Qin H; Sun Z
    Onco Targets Ther; 2017; 10():5031-5046. PubMed ID: 29081665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
    Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.